Characterization of human CD4(+) T-cell clones recognizing conserved and variable epitopes of the Lassa virus nucleoprotein - Wikidata - awgldk - TriplyDB

Characterization of human CD4(+) T-cell clones recognizing conserved and variable epitopes of the Lassa virus nucleoprotein

Characterization of human CD4(+) T-cell clones recognizing conserved and variable epitopes of the Lassa virus nucleoprotein

http://www.wikidata.org/entity/Q33798561

about

Pathogenesis of Lassa fever Advanced vaccine candidates for Lassa fever Envelope exchange for the generation of live-attenuated arenavirus vaccines Lassa fever virus peptides predicted by computational analysis induce epitope-specific cytotoxic-T-lymphocyte responses in HLA-A2.1 transgenic mice.A recombinant Yellow Fever 17D vaccine expressing Lassa virus glycoproteins.A live attenuated vaccine for Lassa fever made by reassortment of Lassa and Mopeia viruses.Early and strong immune responses are associated with control of viral replication and recovery in lassa virus-infected cynomolgus monkeys.A multivalent and cross-protective vaccine strategy against arenaviruses associated with human disease.VaxCelerate II: rapid development of a self-assembling vaccine for Lassa fever.Polyfunctional CD4+ T cell responses to a set of pathogenic arenaviruses provide broad population coverage Coverage of related pathogenic species by multivalent and cross-protective vaccine design: arenaviruses as a model system Characterization of human immunodeficiency virus type 1 (HIV-1) Gag- and Gag peptide-specific CD4(+) T-cell clones from an HIV-1-seronegative donor following in vitro immunization Towards a human Lassa fever vaccine.Pathogenesis of arenavirus hemorrhagic fevers.Vaccination strategies against highly pathogenic arenaviruses: the next steps toward clinical trials Identification of protective Lassa virus epitopes that are restricted by HLA-A2.Human dendritic cells infected with the nonpathogenic Mopeia virus induce stronger T-cell responses than those infected with Lassa virus.Genomic profiling of host responses to Lassa virus: therapeutic potential from primate to man A ML29 reassortant virus protects guinea pigs against a distantly related Nigerian strain of Lassa virus and can provide sterilizing immunity Arenavirus Glycan Shield Promotes Neutralizing Antibody Evasion and Protracted Infection.Lassa virus.Chimeric Mice with Competent Hematopoietic Immunity Reproduce Key Features of Severe Lassa Fever.The search for animal models for Lassa fever vaccine development Vaccine Platforms to Control Arenaviral Hemorrhagic Fevers Mucosal immunization with Salmonella typhimurium expressing Lassa virus nucleocapsid protein cross-protects mice from lethal challenge with lymphocytic choriomeningitis virus.Mucosal arenavirus infection of primates can protect them from lethal hemorrhagic fever.Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primates.Imported lassa fever in Germany: molecular characterization of a new lassa virus strain Production of CXC and CC chemokines by human antigen-presenting cells in response to Lassa virus or closely related immunogenic viruses, and in cynomolgus monkeys with lassa fever.Arenavirus evasion of host anti-viral responses.Immune responses and Lassa virus infection.Vaccine platforms to control Lassa fever.Structure-function relationship of the mammarenavirus envelope glycoprotein.Differential Immune Responses to New World and Old World Mammalian Arenaviruses.Characterization of Lassa virus cell entry and neutralization with Lassa virus pseudoparticles A Case of Human Lassa Virus Infection With Robust Acute T-Cell Activation and Long-Term Virus-Specific T-Cell Responses.NK cells are strongly activated by Lassa and Mopeia virus-infected human macrophages in vitro but do not mediate virus suppression.Alphavirus vector-based replicon particles expressing multivalent cross-protective Lassa virus glycoproteins.Mammarenaviral Infection Is Dependent on Directional Exposure to and Release from Polarized Intestinal Epithelia.Baseline mapping of Lassa fever virology, epidemiology and vaccine research and development.

P2860

Q24613450-CF5170DB-7248-453A-BB5A-AD91F6335786 Q26823627-E028DBE0-4EE5-4E24-9CF0-C8AC6D3E8732 Q27320211-667BB592-DA88-45A4-9192-513511C0FF13 Q27472584-9E8853CD-AC40-4274-BDD7-2981A2207A80 Q27473027-77A8FA5A-FC7B-4FA8-9917-9AFC17F54B29 Q33226128-E0BC724F-AEE2-4235-A709-C94BBF0B63A9 Q33383772-F1A3AF5F-AA58-41FE-99A3-E6207C3C2639 Q33519507-8D54448A-19D9-4668-AB6C-18CAD949C820 Q33723534-902CE8B0-D5AA-4DE3-983A-7D37A8D4F903 Q33892499-E987C3E8-8CE6-480C-BCE4-BEFAA452B462 Q33909096-A7D39EF5-D2A4-41FB-BBC6-CF86245D60BD Q34342413-ECDB6F46-8132-4323-9CE3-A154A13E91C3 Q34394797-2F46633A-05BA-43D8-BCBF-EC4A1674C86F Q34625899-FAEA7426-CC7C-4745-83D1-D25FD51FBCFD Q34671806-C5F7C3BC-5897-4C01-A0EC-B2F9A1B501B1 Q35024149-F7C594BA-D9C2-4290-AAFA-75B8C670496C Q35140402-6929A530-8238-481B-BE27-D9573FB270B9 Q35248863-6801E24A-C504-4729-8F49-C3E5C16463C5 Q35842756-738678C8-0D99-43F9-B9D9-F16152F67F9D Q35847032-31C9CE54-4F85-4A7F-9E94-8A9797F80330 Q35919691-38257356-4C80-4A03-8367-462DC45287A7 Q36020913-0BF75889-5BFF-44EB-B99A-63327F2F5A59 Q36588064-ED7313B2-7CA9-4AC8-9C3D-F399043DC781 Q36612929-50CF8EC1-8816-4A6E-9C51-C823E11944EE Q36667058-C19ED00A-290A-460A-B7BE-4E061130E8D6 Q36925354-6E52F78A-6C68-4386-BB19-FFCCCBA8225A Q36970552-871200E6-2CA4-4CF9-BBE4-E7A165A08F9B Q37064973-D1D90360-9CDC-43C9-AC19-FD8F0775E936 Q37464889-834513AC-AB8B-4D3B-AFE6-B290E41CDB62 Q38064279-384D9AC2-69F1-421B-89EF-CAF217EEAF10 Q38064284-1FAD0CC4-F37F-4E0E-89BE-CF518603652D Q38823264-B0447291-F475-44D8-863F-F521DE9A944A Q38937488-AF881C26-33F7-4CF4-BC22-A763D5A4EE70 Q39302482-A8DCA86A-F4C3-4A39-8949-C48DB40E8F42 Q39893565-53C412B3-B57F-4E8B-BB2D-E28393DF7B1B Q40040969-B3BA0732-E816-4455-AC6A-6893BD822E1E Q40287006-156B7B0E-9025-40B3-B989-A4EE991EE24D Q47244680-6D42C97F-12EF-467D-ABC3-F6B8A89C18D0 Q50034248-5B5915E5-7F4B-46AF-BA68-ED1F22E12CC8 Q52723914-A404B355-4E92-474E-98C7-D2B64C1FD51D

P2860

Characterization of human CD4(+) T-cell clones recognizing conserved and variable epitopes of the Lassa virus nucleoprotein

http://www.wikidata.org/entity/Q33798561

description

2000 nî lūn-bûn

@nan

2000 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի մարտին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Characterization of human CD4( ...... the Lassa virus nucleoprotein

@ast

Characterization of human CD4( ...... the Lassa virus nucleoprotein

@en

type

label

Characterization of human CD4( ...... the Lassa virus nucleoprotein

@ast

Characterization of human CD4( ...... the Lassa virus nucleoprotein

@en

prefLabel

Characterization of human CD4( ...... the Lassa virus nucleoprotein

@ast

Characterization of human CD4( ...... the Lassa virus nucleoprotein

@en

P1433

Q33798561-4222D788-A110-42C5-8F47-AB3A11F79D17

P1476

Q33798561-382DFBB5-798C-46DB-B346-61C17EDFB5DB

P2093

Q33798561-380299EF-EBD5-4548-9F43-4A63346F438B

Q33798561-48234960-3262-4570-98A7-D04F75957DD2

Q33798561-4A4710AA-9F1B-4950-A800-6D3490A4D7F0

Q33798561-5A08C20D-2DDD-4F35-8CC1-0BA398C6EA64

Q33798561-6225E9B9-757B-47C0-B9CC-1B0CEB5B93FD

Q33798561-65CC02F7-F6BB-46C9-A192-C366CA260F2D

Q33798561-6A78444C-1F31-413E-AB6E-4C10FD197AD1

Q33798561-A0EEE1EF-EB63-4333-9D35-519ED9DCCE96

Q33798561-A5C66E90-CEE5-4AC6-AAD1-C579A9D0D162

Q33798561-E0ADCAF7-A9B4-47EB-BD64-211971140988

P2860

Q33798561-294E6C8B-BDE8-4513-96B6-B554CB913D13

Q33798561-36F72677-B2B2-48FD-99C8-7AC6900610F2

Q33798561-3D0490AD-E7AE-47C6-B638-3B11B3C7FA79

Q33798561-3D1E17C0-6363-41EC-913F-8B1F23A8D1D3

Q33798561-403BE540-F23F-4C8E-A752-65162A3E5309

Q33798561-4D523523-5F95-41F6-9C73-DFD29E79325B

Q33798561-4ED611B5-A85E-41D6-AD34-E074CFB20303

Q33798561-5686C9B6-5931-4095-AA7A-4CF1D8B88252

Q33798561-5750BD13-7906-4E32-B248-B3B689453CA4

Q33798561-5A56DC46-47D2-45AC-BC9E-12905B9D8A47

P304

Q33798561-A3F3477C-FD84-4B5D-B84A-BC6BE35A531E

P31

Q33798561-C33B7BE5-01B5-479A-8232-FF697EACDE82

P356

Q33798561-F9649426-9201-423F-A750-55F411F69A54

P433

Q33798561-BB546EFE-0C9A-409A-B24D-2B6939C42D50

P478

Q33798561-14125D66-4BBD-4A31-8AF1-669F58EBDC25

P577

Q33798561-AA018079-5F45-4578-8F1F-C7723F69055B

P5875

Q33798561-298BFF81-22EA-4B3A-8ECF-8A71BE27F0EC

P698

Q33798561-9A1D1F50-C3E3-4570-ACAE-69FFF4128F02

P921

Q33798561-8F215F19-AACF-45B5-A378-A3EF12CEDD3D

P932

Q33798561-524252B9-3FCF-4A85-82F5-82EFC2D3352C

P356

JVI.74.5.2186-2192.2000

P1433

Journal of Virology

P1476

Characterization of human CD4( ...... the Lassa virus nucleoprotein

@en

P2093

A Doetze

http://www.w3.org/2001/XMLSchema#string

A Hoerauf

http://www.w3.org/2001/XMLSchema#string

B Fleischer

http://www.w3.org/2001/XMLSchema#string

C Loeliger

http://www.w3.org/2001/XMLSchema#string

H Schmitz

http://www.w3.org/2001/XMLSchema#string

J Satoguina

http://www.w3.org/2001/XMLSchema#string

J ter Meulen

http://www.w3.org/2001/XMLSchema#string

K Koulemou

http://www.w3.org/2001/XMLSchema#string

K Kuhnt

http://www.w3.org/2001/XMLSchema#string

L Koivogui

http://www.w3.org/2001/XMLSchema#string

P2860

Viral immune evasion due to persistence of activated T cells without effector function

Host-parasite interaction in human onchocerciasis: identification and sequence analysis of a novel human calgranulin

Long-term CD4 Th1 and Th2 memory following acute lymphocytic choriomeningitis virus infection

Protection of rhesus monkeys from fatal Lassa fever by vaccination with a recombinant vaccinia virus containing the Lassa virus glycoprotein gene

Clinical virology of Lassa fever in hospitalized patients.

Current progress towards vaccines for arenavirus-caused diseases.

CD40-CD40 ligand interactions are critical in T-B cooperation but not for other anti-viral CD4+ T cell functions.

CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection.

Cross-protection against lymphocytic choriomeningitis virus mediated by a CD4+ T-cell clone specific for an envelope glycoprotein epitope of Lassa virus.

Massive expansion of antigen-specific CD8+ T cells during an acute virus infection.

P304

2186-2192

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.74.5.2186-2192.2000

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

74

http://www.w3.org/2001/XMLSchema#string

P577

2000-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12649579

http://www.w3.org/2001/XMLSchema#string

P698

10666248

http://www.w3.org/2001/XMLSchema#string

P921

P932

111699

http://www.w3.org/2001/XMLSchema#string